CHD Risk-Equivalent Disease
1 clinical trials · Condition
◉ Watch CHD Risk-Equivalent Disease
| Record | Firm | Date |
|---|---|---|
| Study to Assess the Tolerability and Efficacy of Anacetrapib in Patients With Coronary Heart Disease (CHD) or CHD Risk-Equivalent Disease (MK-0859-019) (NCT00685776) | Merck Sharp & Dohme LLC | 2008-03-24 |
Track CHD Risk-Equivalent Disease automatically
Every clearance here is in the API, with alerts when new ones post.